As the legislation is now constituted, the measures in to identify the drugs by way of colour or container in a specific fashion would prevent diversion, and that is true of many of the drugs that are coming from various sources.
The problem isn't so much, frankly, one of diversion. That hasn't been a vexing difficulty in most of the African countries with high prevalence rates. What they need is security--sustainability of supply and of resources. They obviously need some help with training and retraining to fill the gaps of human capacity, and they obviously need some help in the repair of the infrastructure, but if we could be sure that there were countries of significant capability, both within Africa and outside Africa, who could supply a flow of generic drugs at a very low price, then I think that if the G8 delivers on the promises it has made in terms of financing, we would be able ultimately to confront the pandemic.